Layland Joanne, Grieve David J, Cave Alison C, Sparks Emma, Solaro R John, Shah Ajay M
Department of Cardiology, King's College London, SE5 9PJ, UK.
J Physiol. 2004 May 1;556(Pt 3):835-47. doi: 10.1113/jphysiol.2004.061176. Epub 2004 Feb 13.
PKA-dependent phosphorylation of cardiac troponin I (cTnI) contributes significantly to beta-adrenergic agonist-induced acceleration of myocardial relaxation (lusitropy). However, the role of PKA-dependent cTnI phosphorylation in the positive inotropic response to beta-adrenergic stimulation is unclear. We studied the contractile response to isoprenaline (10 nm) in isolated hearts and isolated cardiomyocytes from transgenic mice with cardiac-specific expression of slow skeletal TnI (ssTnI, which lacks the N-terminal protein extension containing PKA-sensitive phosphorylation sites in cTnI) and matched wild-type littermate controls. As expected, the lusitropic effect of isoprenaline was significantly blunted in ssTnI hearts. However, the positive inotropic response to isoprenaline was also blunted in ssTnI hearts. This effect was especially prominent for ejection-phase indices in isolated auxotonically loaded ssTnI hearts whereas the positive inotropic response of isovolumic hearts or unloaded isolated myocytes was much less affected. Isoprenaline decreased left ventricular end-systolic volume in wild-type hearts (10.6 +/- 1.6 to 6.2 +/- 0.4 microl at a preload of 20 cmH(2)O; P < 0.05) but not transgenic hearts (11.4 +/- 1.3 to 10.9 +/- 1.3 microl; P= n.s.). Likewise, isoprenaline increased stroke work in control hearts (14.5 +/- 1.0 to 22.5 +/- 1.8 mmHg microl mg(-1); P < 0.05) but not transgenic hearts (15.4 +/- 1.3 to 18.3 +/- 1.2 mmHg microl mg(-1); P= n.s.). The end-systolic pressure-volume relation was increased by isoprenaline to a greater extent in control than transgenic hearts. However, isoprenaline induced a similar rise in intracellular Ca(2+) transients in transgenic and non-transgenic cardiomyocytes. These results indicate that cTnI has a pivotal role in the positive inotropic response of the murine heart to beta-adrenergic stimulation, an effect that is highly dependent on loading conditions and is most evident in the auxotonically loaded ejecting heart.
蛋白激酶A(PKA)依赖性的心肌肌钙蛋白I(cTnI)磷酸化对β-肾上腺素能激动剂诱导的心肌舒张加速(舒张功能)有显著贡献。然而,PKA依赖性cTnI磷酸化在β-肾上腺素能刺激的正性肌力反应中的作用尚不清楚。我们研究了来自心脏特异性表达慢肌骨骼肌肌钙蛋白I(ssTnI,其缺乏cTnI中含PKA敏感磷酸化位点的N端蛋白延伸)的转基因小鼠和匹配的野生型同窝对照的离体心脏和离体心肌细胞对异丙肾上腺素(10 nM)的收缩反应。正如预期的那样,异丙肾上腺素的舒张功能效应在ssTnI心脏中明显减弱。然而,ssTnI心脏对异丙肾上腺素的正性肌力反应也减弱。这种效应在离体被动加载的ssTnI心脏的射血期指标中尤为突出,而异容心脏或未加载的离体心肌细胞的正性肌力反应受影响较小。异丙肾上腺素使野生型心脏的左心室收缩末期容积减小(在20 cmH₂O的前负荷下,从10.6±1.6微升降至6.2±0.4微升;P<0.05),但转基因心脏中未减小(从11.4±1.3微升降至10.9±1.3微升;P=无显著差异)。同样,异丙肾上腺素使对照心脏的搏功增加(从14.5±1.0 mmHg微升毫克⁻¹增至22.5±1.8 mmHg微升毫克⁻¹;P<0.05),但转基因心脏中未增加(从15.4±1.3 mmHg微升毫克⁻¹增至18.3±1.2 mmHg微升毫克⁻¹;P=无显著差异)。异丙肾上腺素使对照心脏的收缩末期压力-容积关系增加的程度大于转基因心脏。然而,异丙肾上腺素在转基因和非转基因心肌细胞中诱导的细胞内Ca²⁺瞬变升高相似。这些结果表明,cTnI在小鼠心脏对β-肾上腺素能刺激的正性肌力反应中起关键作用,这种效应高度依赖于负荷条件,在被动加载的射血心脏中最为明显。